Interestingly, CEP55 expression was also elevated in twelve different cancer types, including colorectal, lung, breast, liver hepatocellular, kidney renal clear cell, kidney renal papillary cell, bladder urothelial, uterine corpus endometrial, stomach, thyroid, and prostate cancers (Figure 1B). This evidence concerns the gene CEP55 and prostate carcinoma.